Clinical Trials

Friends of Cancer Research named Edward S. Kim, MD, MBA, FACP, FASCO, one of the top cancer leaders in the nation.

The Leukemia & Lymphoma Society will collaborate with three major cancer centers to provide minority and other underserved populations with greater access to blood cancer clinical trials.

Late last year, the FDA’s Peripheral and Central Nervous System Drugs Advisory Committee met to discuss a Biologics License Application for aducanumab, an anti-amyloid antibody in development for Alzheimer’s disease.

Although patients in underrepresented groups present with worse outcomes than white patients, pancreatic cancer trials fail to represent non-white patients, according to a presentation at Digestive Diseases Week.

The Society for Cardiovascular and Angiography Interventions announced the launch of a new journal, the Journal of the Society for Cardiovascular Angiography and Interventions.

Acute stroke trials underenrolled women, and trials with an upper age threshold of 80 years further limited enrollment, according to findings from a database search of more than 100 trials published in JAMA Neurology.

Reducing the cancer mortality rate by 4% per year through 2026 would cut the rate to half of its all-time peak, NCI Director Norman E. “Ned” Sharpless, MD, told attendees of the virtual American Association for Cancer Research Annual Meeting.

When it comes to federally funded research, Black patients continue to participate in clinical trials less frequently than their white counterparts.

Patient-clinician agreement for symptomatic adverse events in phase 1 trials appeared moderate to poor, suggesting clinicians are underreporting toxicity, according to a study published in Journal of the National Cancer Institute.

Craig Lockhart, MD, has been appointed chief of the division of hematology and oncology at Medical University of South Carolina.